Comparison of fidaxomicin to oral vancomycin for the treatment of Clostridioides difficile infection in hospitalized patients

Background: Clostridioides difficile infection (CDI) is a major source of morbidity and mortality. Even after recovery, recurrent CDI (rCDI) occurs frequently, and concomitant antibiotic use for treatment of a concurrent non–C. difficile infection is a major risk factor. Treatment with fidaxomicin v...

Descripción completa

Detalles Bibliográficos
Autores principales: Rao, A. Krishna, Zhao, Qianzi, Krishnan, Jay, Bell, Justin, Henig, Oryan, Daniel, Jolene, Sawaya, Kara, Albin, Owen, Mills, John, Petty, Lindsay, Gregg, Kevin, Kaul, Daniel, Malani, Anurag, Pogue, Jason, Kaye, Keith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
C. Difficile
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615000/
http://dx.doi.org/10.1017/ash.2022.195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615000/
http://dx.doi.org/10.1017/ash.2022.195

Ejemplares similares